ORGANOGENESIS HOLDINGS INC. Operating Leases, Rent Expense
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Operating Leases, Rent Expense of $62.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-08-09
- ORGANOGENESIS HOLDINGS INC. operating leases, rent expense for the quarter ending 2019-06-30 was $62.00K, a 3.33% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. operating leases, rent expense for the quarter ending 2019-03-31 was $62.00K, a 3.33% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. operating leases, rent expense for the quarter ending 2018-06-30 was $60.00K.
- ORGANOGENESIS HOLDINGS INC. operating leases, rent expense for the quarter ending 2018-03-31 was $60.00K.
- ORGANOGENESIS HOLDINGS INC. operating leases, rent expense for fiscal 2018 was $1.55M, a 11.90% decline from fiscal 2017.
- ORGANOGENESIS HOLDINGS INC. operating leases, rent expense for fiscal 2017 was $1.76M, a 28.03% decline from fiscal 2016.
- ORGANOGENESIS HOLDINGS INC. operating leases, rent expense for fiscal 2016 was $2.45M.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|
| 2019-06-30 | $62.00K 10-Q · filed 2019-08-09 | $124.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $62.00K 10-Q · filed 2019-05-10 | ||
| 2018-12-31 | $1.55M 10-K · filed 2019-03-18 | ||
| 2018-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $120.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $60.00K 10-Q · filed 2019-08-09 | ||
| 2017-12-31 | $1.76M 10-K · filed 2019-03-18 | ||
| 2016-12-31 | $2.45M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |